Coherus Management to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Coherus BioSciences (NASDAQ: CHRS) has announced that its senior management will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 5:15 p.m. Pacific Time.
The presentation, which will include a Q&A session, will be accessible via Webcast through a link on the Investor Events Calendar section of the Coherus website. The webcast will be available for replay until February 10, 2025.
For further information, investors can contact Jodi Sievers, VP of Investor Relations & Corporate Communications, at IR@coherus.com.
Positive
- None.
Negative
- None.
News Market Reaction – CHRS
In the trading session that priced this news, CHRS declined 3.82%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that senior management will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 5:15 p.m. Pacific Time. The presentation and Q&A session will be accessible via Webcast through a link posted on the Investor Events Calendar section of the Coherus website: https://investors.coherus.com/events-presentations. This webcast will be available for replay until February 10, 2025.
Coherus Contact Information:
For Investors:
Jodi Sievers
VP, Investor Relations & Corporate Communications
IR@coherus.com